Virpax Pharmaceuticals, Inc. (VRPX)
Develops pain management drugs using new delivery technologies like sprays and injections.
$0.00-0.75%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-99.1%
The outlook
VRPX is trading near its 52-week low with minimal analyst coverage. The stock sits well below both its 50- and 200-day moving averages, reflecting a sustained downtrend. Current sentiment leans heavily bearish based on available market data.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$124
52-wk high
$0.10
52-wk low
$0.00
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
—